Zinc and Copper Ions Differentially Regulate Prion-Like Phase Separation Dynamics of Pan-Virus Nucleocapsid Biomolecular Condensates
Abstract
:1. Introduction
2. Materials and Methods
2.1. Informatics
2.2. Data and Code Availability
3. Results
3.1. Juxtaposed PrLDs, ZnFs and RRMs in the Most Deadly of Viruses
3.2. Metal Ion Binding Competition for ZnFs and RRMs Alters Protein Aggregate Stoichiometry
3.3. How Zn2+ and Zn2+-Chelation Both Cause Loss of Viral Capsid Integrity
3.4. Environmental Cu2+ as a Means to Control Viruses
3.5. Endogenous Cu2+ as a Means to Control Viruses
4. Discussion and Model Supporting Zn2+- and Cu2+-Mediated Control of Pan-Viruses
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Riback, J.A.; Katanski, C.D.; Kear-Scott, J.L.; Pilipenko, E.V.; Rojek, A.E.; Sosnick, T.R.; Drummond, D.A. Stress-Triggered Phase Separation Is an Adaptive, Evolutionarily Tuned Response. Cell 2017, 168, 1028–1040.e19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Franzmann, T.M.; Alberti, S. Protein Phase Separation as a Stress Survival Strategy. Cold Spring Harb. Perspect. Biol. 2019, 11. [Google Scholar] [CrossRef] [Green Version]
- Kroschwald, S.; Alberti, S. Gel or Die: Phase Separation as a Survival Strategy. Cell 2017, 168, 947–948. [Google Scholar] [CrossRef]
- Aguzzi, A.; Altmeyer, M. Phase Separation: Linking Cellular Compartmentalization to Disease. Trends Cell Biol. 2016, 26, 547–558. [Google Scholar] [CrossRef] [PubMed]
- Elbaum-Garfinkle, S. Matter over mind: Liquid phase separation and neurodegeneration. J. Biol. Chem. 2019, 294, 7160–7168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Molliex, A.; Temirov, J.; Lee, J.; Coughlin, M.; Kanagaraj, A.P.; Kim, H.J.; Mittag, T.; Taylor, J.P. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 2015, 163, 123–133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wegmann, S.; Eftekharzadeh, B.; Tepper, K.; Zoltowska, K.M.; Bennett, R.E.; Dujardin, S.; Laskowski, P.R.; MacKenzie, D.; Kamath, T.; Commins, C.; et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J. 2018, 37. [Google Scholar] [CrossRef] [PubMed]
- Li, P.; Banjade, S.; Cheng, H.C.; Kim, S.; Chen, B.; Guo, L.; Llaguno, M.; Hollingsworth, J.V.; King, D.S.; Banani, S.F.; et al. Phase transitions in the assembly of multivalent signalling proteins. Nature 2012, 483, 336–340. [Google Scholar] [CrossRef]
- Gal, J.; Kuang, L.; Barnett, K.R.; Zhu, B.Z.; Shissler, S.C.; Korotkov, K.V.; Hayward, L.J.; Kasarskis, E.J.; Zhu, H. ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics. Acta Neuropathol. 2016, 132, 563–576. [Google Scholar] [CrossRef] [Green Version]
- Kedersha, N.; Panas, M.D.; Achorn, C.A.; Lyons, S.; Tisdale, S.; Hickman, T.; Thomas, M.; Lieberman, J.; McInerney, G.M.; Ivanov, P.; et al. G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits. J. Cell Biol. 2016, 212, 845–860. [Google Scholar] [CrossRef] [Green Version]
- Poblete-Duran, N.; Prades-Perez, Y.; Vera-Otarola, J.; Soto-Rifo, R.; Valiente-Echeverria, F. Who Regulates Whom? An Overview of RNA Granules and Viral Infections. Viruses 2016, 8, 180. [Google Scholar] [CrossRef] [PubMed]
- Rayman, J.B.; Karl, K.A.; Kandel, E.R. TIA-1 Self-Multimerization, Phase Separation, and Recruitment into Stress Granules Are Dynamically Regulated by Zn(2). Cell Rep. 2018, 22, 59–71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garnier, C.; Devred, F.; Byrne, D.; Puppo, R.; Roman, A.Y.; Malesinski, S.; Golovin, A.V.; Lebrun, R.; Ninkina, N.N.; Tsvetkov, P.O. Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates. Sci. Rep. 2017, 7, 6812. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Singh, V.; Xu, L.; Boyko, S.; Surewicz, K.; Surewicz, W.K. Zinc promotes liquid-liquid phase separation of tau protein. J. Biol. Chem. 2020. [Google Scholar] [CrossRef] [Green Version]
- Rosen, D.R.; Siddique, T.; Patterson, D.; Figlewicz, D.A.; Sapp, P.; Hentati, A.; Donaldson, D.; Goto, J.; O’Regan, J.P.; Deng, H.X.; et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362, 59–62. [Google Scholar] [CrossRef]
- Dang, T.N.; Lim, N.K.; Grubman, A.; Li, Q.X.; Volitakis, I.; White, A.R.; Crouch, P.J. Increased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Front. Aging Neurosci. 2014, 6, 15. [Google Scholar] [CrossRef]
- Guarino, A.M.; Mauro, G.D.; Ruggiero, G.; Geyer, N.; Delicato, A.; Foulkes, N.S.; Vallone, D.; Calabro, V. YB-1 recruitment to stress granules in zebrafish cells reveals a differential adaptive response to stress. Sci. Rep. 2019, 9, 9059. [Google Scholar] [CrossRef] [PubMed]
- Mold, M.; Ouro-Gnao, L.; Wieckowski, B.M.; Exley, C. Copper prevents amyloid-beta(1-42) from forming amyloid fibrils under near-physiological conditions in vitro. Sci. Rep. 2013, 3, 1256. [Google Scholar] [CrossRef] [Green Version]
- Voss, K.; Harris, C.; Ralle, M.; Duffy, M.; Murchison, C.; Quinn, J.F. Modulation of tau phosphorylation by environmental copper. Transl. Neurodegener. 2014, 3, 24. [Google Scholar] [CrossRef] [Green Version]
- Burkhead, J.L.; Ralle, M.; Wilmarth, P.; David, L.; Lutsenko, S. Elevated copper remodels hepatic RNA processing machinery in the mouse model of Wilson’s disease. J. Mol. Biol. 2011, 406, 44–58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Panas, M.D.; Ivanov, P.; Anderson, P. Mechanistic insights into mammalian stress granule dynamics. J. Cell Biol. 2016, 215, 313–323. [Google Scholar] [CrossRef]
- Wang, J.; Choi, J.M.; Holehouse, A.S.; Lee, H.O.; Zhang, X.; Jahnel, M.; Maharana, S.; Lemaitre, R.; Pozniakovsky, A.; Drechsel, D.; et al. A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins. Cell 2018, 174, 688–699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reineke, L.C.; Lloyd, R.E. Diversion of stress granules and P-bodies during viral infection. Virology 2013, 436, 255–267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tsai, W.C.; Lloyd, R.E. Cytoplasmic RNA Granules and Viral Infection. Annu. Rev. Virol. 2014, 1, 147–170. [Google Scholar] [CrossRef] [Green Version]
- Ludwig, C.; Wagner, R. Virus-like particles-universal molecular toolboxes. Curr. Opin. Biotechnol. 2007, 18, 537–545. [Google Scholar] [CrossRef] [PubMed]
- Grgacic, E.V.; Anderson, D.A. Virus-like particles: Passport to immune recognition. Methods 2006, 40, 60–65. [Google Scholar] [CrossRef] [PubMed]
- Novoa, R.R.; Calderita, G.; Arranz, R.; Fontana, J.; Granzow, H.; Risco, C. Virus factories: Associations of cell organelles for viral replication and morphogenesis. Biol. Cell 2005, 97, 147–172. [Google Scholar] [CrossRef] [PubMed]
- Netherton, C.L.; Wileman, T. Virus factories, double membrane vesicles and viroplasm generated in animal cells. Curr. Opin. Virol. 2011, 1, 381–387. [Google Scholar] [CrossRef]
- Wileman, T. Aggresomes and autophagy generate sites for virus replication. Science 2006, 312, 875–878. [Google Scholar] [CrossRef]
- Nikonorova, N.; Vu, L.D.; Czyzewicz, N.; Gevaert, K.; De Smet, I. A phylogenetic approach to study the origin and evolution of the CRINKLY4 family. Front. Plant. Sci. 2015, 6, 880. [Google Scholar] [CrossRef] [Green Version]
- Nikolic, J.; Le Bars, R.; Lama, Z.; Scrima, N.; Lagaudriere-Gesbert, C.; Gaudin, Y.; Blondel, D. Negri bodies are viral factories with properties of liquid organelles. Nat. Commun. 2017, 8, 58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heinrich, B.S.; Maliga, Z.; Stein, D.A.; Hyman, A.A.; Whelan, S.P.J. Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments. MBio 2018, 9. [Google Scholar] [CrossRef] [Green Version]
- Alenquer, M.; Vale-Costa, S.; Etibor, T.A.; Ferreira, F.; Sousa, A.L.; Amorim, M.J. Influenza A virus ribonucleoproteins form liquid organelles at endoplasmic reticulum exit sites. Nat. Commun. 2019, 10, 1629. [Google Scholar] [CrossRef] [Green Version]
- Zhou, Y.; Su, J.M.; Samuel, C.E.; Ma, D. Measles Virus Forms Inclusion Bodies with Properties of Liquid Organelles. J. Virol. 2019. [Google Scholar] [CrossRef] [PubMed]
- McSwiggen, D.T.; Hansen, A.S.; Teves, S.S.; Marie-Nelly, H.; Hao, Y.; Heckert, A.B.; Umemoto, K.K.; Dugast-Darzacq, C.; Tjian, R.; Darzacq, X. Evidence for DNA-mediated nuclear compartmentalization distinct from phase separation. Elife 2019, 8. [Google Scholar] [CrossRef]
- Nikolic, J.; Lagaudriere-Gesbert, C.; Scrima, N.; Blondel, D.; Gaudin, Y. Structure and Function of Negri Bodies. Adv. Exp. Med. Biol. 2019, 1140, 111–127. [Google Scholar] [CrossRef]
- Lifland, A.W.; Jung, J.; Alonas, E.; Zurla, C.; Crowe, J.E., Jr.; Santangelo, P.J. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J. Virol. 2012, 86, 8245–8258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kondo, H.; Chiba, S.; Andika, I.B.; Maruyama, K.; Tamada, T.; Suzuki, N. Orchid fleck virus structural proteins N and P form intranuclear viroplasm-like structures in the absence of viral infection. J. Virol. 2013, 87, 7423–7434. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brick, D.J.; Burke, R.D.; Schiff, L.; Upton, C. Shope fibroma virus RING finger protein N1R binds DNA and inhibits apoptosis. Virology 1998, 249, 42–51. [Google Scholar] [CrossRef] [Green Version]
- Nerenberg, B.T.; Taylor, J.; Bartee, E.; Gouveia, K.; Barry, M.; Fruh, K. The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories. J. Virol. 2005, 79, 597–601. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Senkevich, T.G.; Wolffe, E.J.; Buller, R.M. Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J. Virol. 1995, 69, 4103–4111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fehling, S.K.; Lennartz, F.; Strecker, T. Multifunctional nature of the arenavirus RING finger protein Z. Viruses 2012, 4, 2973–3011. [Google Scholar] [CrossRef] [Green Version]
- Mathur, C.; Mohan, K.; Usha Rani, T.R.; Krishna Reddy, M.; Savithri, H.S. The N-terminal region containing the zinc finger domain of tobacco streak virus coat protein is essential for the formation of virus-like particles. Arch. Virol. 2014, 159, 413–423. [Google Scholar] [CrossRef] [PubMed]
- Hanslip, S.J.; Zaccai, N.R.; Middelberg, A.P.; Falconer, R.J. Assembly of human papillomavirus type-16 virus-like particles: Multifactorial study of assembly and competing aggregation. Biotechnol. Prog. 2006, 22, 554–560. [Google Scholar] [CrossRef] [PubMed]
- Hoenen, T.; Shabman, R.S.; Groseth, A.; Herwig, A.; Weber, M.; Schudt, G.; Dolnik, O.; Basler, C.F.; Becker, S.; Feldmann, H. Inclusion bodies are a site of ebolavirus replication. J. Virol. 2012, 86, 11779–11788. [Google Scholar] [CrossRef] [Green Version]
- Pushker, R.; Mooney, C.; Davey, N.E.; Jacque, J.M.; Shields, D.C. Marked variability in the extent of protein disorder within and between viral families. PLoS ONE 2013, 8, e60724. [Google Scholar] [CrossRef] [Green Version]
- Tarakhovsky, A.; Prinjha, R.K. Drawing on disorder: How viruses use histone mimicry to their advantage. J. Exp. Med. 2018, 215, 1777–1787. [Google Scholar] [CrossRef] [Green Version]
- Goh, G.K.; Dunker, A.K.; Foster, J.A.; Uversky, V.N. HIV Vaccine Mystery and Viral Shell Disorder. Biomolecules 2019, 9, 178. [Google Scholar] [CrossRef] [Green Version]
- Goh, G.K.; Dunker, A.K.; Foster, J.A.; Uversky, V.N. Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity. Biomolecules 2020, 10, 331. [Google Scholar] [CrossRef] [Green Version]
- Yu, K.L.; Lee, S.H.; Lee, E.S.; You, J.C. HIV-1 nucleocapsid protein localizes efficiently to the nucleus and nucleolus. Virology 2016, 492, 204–212. [Google Scholar] [CrossRef]
- Rao, S.; Cinti, A.; Temzi, A.; Amorim, R.; You, J.C.; Mouland, A.J. HIV-1 NC-induced stress granule assembly and translation arrest are inhibited by the dsRNA binding protein Staufen1. RNA 2018, 24, 219–236. [Google Scholar] [CrossRef]
- Valiente-Echeverria, F.; Melnychuk, L.; Vyboh, K.; Ajamian, L.; Gallouzi, I.E.; Bernard, N.; Mouland, A.J. eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection. Nat. Commun. 2014, 5, 4819. [Google Scholar] [CrossRef] [Green Version]
- Abrahamyan, L.G.; Chatel-Chaix, L.; Ajamian, L.; Milev, M.P.; Monette, A.; Clement, J.F.; Song, R.; Lehmann, M.; DesGroseillers, L.; Laughrea, M.; et al. Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA. J. Cell Sci. 2010, 123, 369–383. [Google Scholar] [CrossRef] [Green Version]
- Muriaux, D.; Darlix, J.L. Properties and functions of the nucleocapsid protein in virus assembly. RNA Biol. 2010, 7, 744–753. [Google Scholar] [CrossRef] [PubMed]
- Monette, A.; Niu, M.; Chen, L.; Rao, S.; Gorelick, R.J.; Mouland, A.J. Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking. Cell Rep. 2020, 31, 107520. [Google Scholar] [CrossRef]
- Guseva, S.; Milles, S.; Jensen, M.R.; Salvi, N.; Kleman, J.P.; Maurin, D.; Ruigrok, R.W.H.; Blackledge, M. Measles virus nucleo- and phosphoproteins form liquid-like phase-separated compartments that promote nucleocapsid assembly. Sci. Adv. 2020, 6, eaaz7095. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Perdikari, T.M.; Murthy, A.C.; Ryan, V.H.; Watters, S.; Naik, M.T.; Fawzi, N.L. SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. BioRxiv 2020. [Google Scholar] [CrossRef]
- Iserman, C.; Roden, C.; Boerneke, M.; Sealfon, R.; McLaughlin, G.; Jungreis, I.; Park, C.; Boppana, A.; Fritch, E.; Hou, Y.J.; et al. Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. BioRxiv 2020. [Google Scholar] [CrossRef]
- Cubuk, J.; Alston, J.J.; Incicco, J.J.; Singh, S.; Stuchell-Brereton, M.D.; Ward, M.D.; Zimmerman, M.I.; Vithani, N.; Griffith, D.; Wagoner, J.A.; et al. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA. BioRxiv 2020. [Google Scholar] [CrossRef]
- Carlson, C.R.; Asfaha, J.B.; Ghent, C.M.; Howard, C.J.; Hartooni, N.; Morgan, D.O. Phosphorylation modulates liquid-liquid phase separation of the SARS-CoV-2 N protein. BioRxiv 2020. [Google Scholar] [CrossRef]
- Chen, H.; Cui, Y.; Han, X.; Hu, W.; Sun, M.; Zhang, Y.; Wang, P.H.; Song, G.; Chen, W.; Lou, J. Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA. Cell Res. 2020. [Google Scholar] [CrossRef] [PubMed]
- Cumberworth, A.; Lamour, G.; Babu, M.M.; Gsponer, J. Promiscuity as a functional trait: Intrinsically disordered regions as central players of interactomes. Biochem. J. 2013, 454, 361–369. [Google Scholar] [CrossRef] [Green Version]
- Jones, S. Protein-RNA interactions: Structural biology and computational modeling techniques. Biophys. Rev. 2016, 8, 359–367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dumetz, A.C.; Chockla, A.M.; Kaler, E.W.; Lenhoff, A.M. Protein phase behavior in aqueous solutions: Crystallization, liquid-liquid phase separation, gels, and aggregates. Biophys. J. 2008, 94, 570–583. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boeynaems, S.; Alberti, S.; Fawzi, N.L.; Mittag, T.; Polymenidou, M.; Rousseau, F.; Schymkowitz, J.; Shorter, J.; Wolozin, B.; Van Den Bosch, L.; et al. Protein Phase Separation: A New Phase in Cell Biology. Trends Cell Biol. 2018, 28, 420–435. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mullard, A. Biomolecular condensates pique drug discovery curiosity. Nat. Rev. Drug. Discov. 2019. [Google Scholar] [CrossRef]
- Dyson, H.J. Roles of intrinsic disorder in protein-nucleic acid interactions. Mol. Biosyst. 2012, 8, 97–104. [Google Scholar] [CrossRef] [Green Version]
- Bellmann, J.; Monette, A.; Tripathy, V.; Sojka, A.; Abo-Rady, M.; Janosh, A.; Bhatnagar, R.; Bickle, M.; Mouland, A.J.; Sterneckert, J. Viral Infections Exacerbate FUS-ALS Phenotypes in iPSC-Derived Spinal Neurons in a Virus Species-Specific Manner. Front. Cell Neurosci. 2019, 13, 480. [Google Scholar] [CrossRef]
- Shelkovnikova, T.A.; An, H.; Skelt, L.; Tregoning, J.S.; Humphreys, I.R.; Buchman, V.L. Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis. Cell Rep. 2019, 29, 4496–4508. [Google Scholar] [CrossRef] [Green Version]
- Alfahad, T.; Nath, A. Retroviruses and amyotrophic lateral sclerosis. Antivir. Res. 2013, 99, 180–187. [Google Scholar] [CrossRef] [Green Version]
- Fields, J.A.; Spencer, B.; Swinton, M.; Qvale, E.M.; Marquine, M.J.; Alexeeva, A.; Gough, S.; Soontornniyomkij, B.; Valera, E.; Masliah, E.; et al. Alterations in brain TREM2 and Amyloid-beta levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J. Neurochem. 2018, 147, 784–802. [Google Scholar] [CrossRef] [Green Version]
- Howdle, G.C.; Quide, Y.; Kassem, M.S.; Johnson, K.; Rae, C.D.; Brew, B.J.; Cysique, L.A. Brain amyloid in virally suppressed HIV-associated neurocognitive disorder. Neurol. Neuroimmunol. Neuroinflamm. 2020, 7. [Google Scholar] [CrossRef]
- Peng, K.; Vucetic, S.; Radivojac, P.; Brown, C.J.; Dunker, A.K.; Obradovic, Z. Optimizing long intrinsic disorder predictors with protein evolutionary information. J. Bioinform. Comput. Biol. 2005, 3, 35–60. [Google Scholar] [CrossRef]
- Sigrist, C.J.; de Castro, E.; Cerutti, L.; Cuche, B.A.; Hulo, N.; Bridge, A.; Bougueleret, L.; Xenarios, I. New and continuing developments at PROSITE. Nucleic Acids Res. 2013, 41, D344–D347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dong, S.; Yang, P.; Li, G.; Liu, B.; Wang, W.; Liu, X.; Xia, B.; Yang, C.; Lou, Z.; Guo, Y.; et al. Insight into the Ebola virus nucleocapsid assembly mechanism: Crystal structure of Ebola virus nucleoprotein core domain at 1.8 A resolution. Protein Cell 2015, 6, 351–362. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Letunic, I.; Bork, P. Interactive Tree Of Life (iTOL) v4: Recent updates and new developments. Nucleic Acids Res. 2019, 47, W256–W259. [Google Scholar] [CrossRef] [Green Version]
- Uversky, V.N.; Gillespie, J.R.; Fink, A.L. Why are “natively unfolded” proteins unstructured under physiologic conditions? Proteins 2000, 41, 415–427. [Google Scholar] [CrossRef]
- Lancaster, A.K.; Nutter-Upham, A.; Lindquist, S.; King, O.D. PLAAC: A web and command-line application to identify proteins with prion-like amino acid composition. Bioinformatics 2014, 30, 2501–2502. [Google Scholar] [CrossRef] [Green Version]
- Romero, P.; Obradovic, Z.; Li, X.; Garner, E.C.; Brown, C.J.; Dunker, A.K. Sequence complexity of disordered protein. Proteins 2001, 42, 38–48. [Google Scholar] [CrossRef]
- Peng, K.; Radivojac, P.; Vucetic, S.; Dunker, A.K.; Obradovic, Z. Length-dependent prediction of protein intrinsic disorder. BMC Bioinform. 2006, 7, 208. [Google Scholar] [CrossRef] [Green Version]
- Piovesan, D.; Tabaro, F.; Paladin, L.; Necci, M.; Micetic, I.; Camilloni, C.; Davey, N.; Dosztanyi, Z.; Meszaros, B.; Monzon, A.M.; et al. MobiDB 3.0: More annotations for intrinsic disorder, conformational diversity and interactions in proteins. Nucleic Acids Res. 2018, 46, D471–D476. [Google Scholar] [CrossRef] [PubMed]
- Brottier, P.; Nandi, P.; Bremont, M.; Cohen, J. Bovine rotavirus segment 5 protein expressed in the baculovirus system interacts with zinc and RNA. J. Gen. Virol. 1992, 73, 1931–1938. [Google Scholar] [CrossRef] [PubMed]
- Hwang, J.; Huang, L.; Cordek, D.G.; Vaughan, R.; Reynolds, S.L.; Kihara, G.; Raney, K.D.; Kao, C.C.; Cameron, C.E. Hepatitis C virus nonstructural protein 5A: Biochemical characterization of a novel structural class of RNA-binding proteins. J. Virol. 2010, 84, 12480–12491. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, T.; Ye, Z. Restriction of viral replication by mutation of the influenza virus matrix protein. J. Virol. 2002, 76, 13055–13061. [Google Scholar] [CrossRef] [Green Version]
- Dahmani, I.; Ludwig, K.; Chiantia, S. Influenza A matrix protein M1 induces lipid membrane deformation via protein multimerization. Biosci. Rep. 2019, 39. [Google Scholar] [CrossRef] [Green Version]
- Madsen, J.J.; Grime, J.M.A.; Rossman, J.S.; Voth, G.A. Entropic forces drive clustering and spatial localization of influenza A M2 during viral budding. Proc. Natl. Acad. Sci. USA 2018, 115, E8595–E8603. [Google Scholar] [CrossRef] [Green Version]
- Liu, T.; Ye, Z. Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein. J. Virol. 2004, 78, 9585–9591. [Google Scholar] [CrossRef] [Green Version]
- Lin, S.Y.; Liu, C.L.; Chang, Y.M.; Zhao, J.; Perlman, S.; Hou, M.H. Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target. J. Med. Chem. 2014, 57, 2247–2257. [Google Scholar] [CrossRef] [Green Version]
- Degenkolbe, R.; Gilligan, P.; Gupta, S.; Bernard, H.U. Chelating agents stabilize the monomeric state of the zinc binding human papillomavirus 16 E6 oncoprotein. Biochemistry 2003, 42, 3868–3873. [Google Scholar] [CrossRef]
- Zanier, K.; ould M’hamed ould Sidi, A.; Boulade-Ladame, C.; Rybin, V.; Chappelle, A.; Atkinson, A.; Kieffer, B.; Trave, G. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure 2012, 20, 604–617. [Google Scholar] [CrossRef] [Green Version]
- Dhillon, P.; Rao, C.D. Rotavirus Induces Formation of Remodeled Stress Granules and P Bodies and Their Sequestration in Viroplasms To Promote Progeny Virus Production. J. Virol. 2018, 92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kattoura, M.D.; Clapp, L.L.; Patton, J.T. The rotavirus nonstructural protein, NS35, possesses RNA-binding activity in vitro and in vivo. Virology 1992, 191, 698–708. [Google Scholar] [CrossRef]
- Cui, T.; Sugrue, R.J.; Xu, Q.; Lee, A.K.; Chan, Y.C.; Fu, J. Recombinant dengue virus type 1 NS3 protein exhibits specific viral RNA binding and NTPase activity regulated by the NS5 protein. Virology 1998, 246, 409–417. [Google Scholar] [CrossRef] [Green Version]
- Huang, L.; Hwang, J.; Sharma, S.D.; Hargittai, M.R.; Chen, Y.; Arnold, J.J.; Raney, K.D.; Cameron, C.E. Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J. Biol. Chem. 2005, 280, 36417–36428. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chang, C.K.; Hsu, Y.L.; Chang, Y.H.; Chao, F.A.; Wu, M.C.; Huang, Y.S.; Hu, C.K.; Huang, T.H. Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: Implications for ribonucleocapsid protein packaging. J. Virol. 2009, 83, 2255–2264. [Google Scholar] [CrossRef] [Green Version]
- Taraporewala, Z.F.; Patton, J.T. Nonstructural proteins involved in genome packaging and replication of rotaviruses and other members of the Reoviridae. Virus Res. 2004, 101, 57–66. [Google Scholar] [CrossRef] [Green Version]
- Hua, J.; Mansell, E.A.; Patton, J.T. Comparative analysis of the rotavirus NS53 gene: Conservation of basic and cysteine-rich regions in the protein and possible stem-loop structures in the RNA. Virology 1993, 196, 372–378. [Google Scholar] [CrossRef]
- Erk, I.; Huet, J.C.; Duarte, M.; Duquerroy, S.; Rey, F.; Cohen, J.; Lepault, J. A zinc ion controls assembly and stability of the major capsid protein of rotavirus. J. Virol. 2003, 77, 3595–3601. [Google Scholar] [CrossRef] [Green Version]
- Trask, S.D.; McDonald, S.M.; Patton, J.T. Structural insights into the coupling of virion assembly and rotavirus replication. Nat. Rev. Microbiol. 2012, 10, 165–177. [Google Scholar] [CrossRef] [Green Version]
- Liu, C.L.; Hung, H.C.; Lo, S.C.; Chiang, C.H.; Chen, I.J.; Hsu, J.T.; Hou, M.H. Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development. Sci. Rep. 2016, 6, 21662. [Google Scholar] [CrossRef]
- Porterfield, J.Z.; Dhason, M.S.; Loeb, D.D.; Nassal, M.; Stray, S.J.; Zlotnick, A. Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J. Virol. 2010, 84, 7174–7184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- John, S.P.; Wang, T.; Steffen, S.; Longhi, S.; Schmaljohn, C.S.; Jonsson, C.B. Ebola virus VP30 is an RNA binding protein. J. Virol. 2007, 81, 8967–8976. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Biryukov, J.; Meyers, C. Papillomavirus Infectious Pathways: A Comparison of Systems. Viruses 2015, 7, 2823. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mir, M.A.; Panganiban, A.T. The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding. J. Virol. 2005, 79, 1824–1835. [Google Scholar] [CrossRef] [Green Version]
- Ivanyi-Nagy, R.; Kanevsky, I.; Gabus, C.; Lavergne, J.P.; Ficheux, D.; Penin, F.; Fosse, P.; Darlix, J.L. Analysis of hepatitis C virus RNA dimerization and core-RNA interactions. Nucleic Acids Res. 2006, 34, 2618–2633. [Google Scholar] [CrossRef]
- Ivanyi-Nagy, R.; Lavergne, J.P.; Gabus, C.; Ficheux, D.; Darlix, J.L. RNA chaperoning and intrinsic disorder in the core proteins of Flaviviridae. Nucleic Acids Res. 2008, 36, 712–725. [Google Scholar] [CrossRef]
- Zuniga, S.; Sola, I.; Moreno, J.L.; Sabella, P.; Plana-Duran, J.; Enjuanes, L. Coronavirus nucleocapsid protein is an RNA chaperone. Virology 2007, 357, 215–227. [Google Scholar] [CrossRef] [Green Version]
- Liu, B.; Dong, S.; Li, G.; Wang, W.; Liu, X.; Wang, Y.; Yang, C.; Rao, Z.; Guo, Y. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus. J. Virol. 2017, 91. [Google Scholar] [CrossRef] [Green Version]
- Lahaye, X.; Vidy, A.; Pomier, C.; Obiang, L.; Harper, F.; Gaudin, Y.; Blondel, D. Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication. J. Virol. 2009, 83, 7948–7958. [Google Scholar] [CrossRef] [Green Version]
- Rincheval, V.; Lelek, M.; Gault, E.; Bouillier, C.; Sitterlin, D.; Blouquit-Laye, S.; Galloux, M.; Zimmer, C.; Eleouet, J.F.; Rameix-Welti, M.A. Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus. Nat. Commun. 2017, 8, 563. [Google Scholar] [CrossRef]
- Zhang, S.; Chen, L.; Zhang, G.; Yan, Q.; Yang, X.; Ding, B.; Tang, Q.; Sun, S.; Hu, Z.; Chen, M. An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation. J. Virol. 2013, 87, 12457–12470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Precious, B.; Young, D.F.; Bermingham, A.; Fearns, R.; Ryan, M.; Randall, R.E. Inducible expression of the P, V, and NP genes of the paramyxovirus simian virus 5 in cell lines and an examination of NP-P and NP-V interactions. J. Virol. 1995, 69, 8001–8010. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Derdowski, A.; Peters, T.R.; Glover, N.; Qian, R.; Utley, T.J.; Burnett, A.; Williams, J.V.; Spearman, P.; Crowe, J.E. Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J. Gen. Virol. 2008, 89, 2698–2708. [Google Scholar] [CrossRef] [PubMed]
- Omi-Furutani, M.; Yoneda, M.; Fujita, K.; Ikeda, F.; Kai, C. Novel phosphoprotein-interacting region in Nipah virus nucleocapsid protein and its involvement in viral replication. J. Virol. 2010, 84, 9793–9799. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ma, D.; George, C.X.; Nomburg, J.L.; Pfaller, C.K.; Cattaneo, R.; Samuel, C.E. Upon Infection, Cellular WD Repeat-Containing Protein 5 (WDR5) Localizes to Cytoplasmic Inclusion Bodies and Enhances Measles Virus Replication. J. Virol. 2018, 92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rodionov, V.V.; Teplova, L.P.; Fel’dman, F. Diagnosis of broncho-pulmonary-pleural complications after operations on abdominal organs. Vestn. Khir. Im. I I Grek. 1977, 119, 37–41. [Google Scholar]
- Patil, A.; Nakamura, H. Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks. Febs. Lett. 2006, 580, 2041–2045. [Google Scholar] [CrossRef] [Green Version]
- Uversky, V.N. Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders. Front. Aging Neurosci. 2015, 7, 18. [Google Scholar] [CrossRef] [Green Version]
- Poole, A.M.; Jeffares, D.C.; Penny, D. The path from the RNA world. J. Mol. Evol. 1998, 46, 1–17. [Google Scholar] [CrossRef]
- Tompa, P.; Csermely, P. The role of structural disorder in the function of RNA and protein chaperones. FASEB J. 2004, 18, 1169–1175. [Google Scholar] [CrossRef]
- Mishra, P.M.; Verma, N.C.; Rao, C.; Uversky, V.N.; Nandi, C.K. Intrinsically disordered proteins of viruses: Involvement in the mechanism of cell regulation and pathogenesis. Prog. Mol. Biol. Transl. Sci. 2020, 174, 1–78. [Google Scholar] [CrossRef] [PubMed]
- Hyodo, K.; Kaido, M.; Okuno, T. Host and viral RNA-binding proteins involved in membrane targeting, replication and intercellular movement of plant RNA virus genomes. Front. Plant. Sci. 2014, 5, 321. [Google Scholar] [CrossRef]
- Sasaki, N.; Park, J.W.; Maule, A.J.; Nelson, R.S. The cysteine-histidine-rich region of the movement protein of Cucumber mosaic virus contributes to plasmodesmal targeting, zinc binding and pathogenesis. Virology 2006, 349, 396–408. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mullers, E. The foamy virus Gag proteins: What makes them different? Viruses 2013, 5, 1023–1041. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mitrea, D.M.; Kriwacki, R.W. Phase separation in biology; functional organization of a higher order. Cell Commun. Signal. 2016, 14, 1. [Google Scholar] [CrossRef] [Green Version]
- Chaturvedi, U.C.; Shrivastava, R. Interaction of viral proteins with metal ions: Role in maintaining the structure and functions of viruses. FEMS Immunol. Med. Microbiol. 2005, 43, 105–114. [Google Scholar] [CrossRef] [Green Version]
- Chaigne-Delalande, B.; Lenardo, M.J. Divalent cation signaling in immune cells. Trends Immunol. 2014, 35, 332–344. [Google Scholar] [CrossRef] [Green Version]
- Onuchic, P.L.; Milin, A.N.; Alshareedah, I.; Deniz, A.A.; Banerjee, P.R. Divalent cations can control a switch-like behavior in heterotypic and homotypic RNA coacervates. Sci. Rep. 2019, 9, 12161. [Google Scholar] [CrossRef] [Green Version]
- Shimberg, G.D.; Ok, K.; Neu, H.M.; Splan, K.E.; Michel, S.L.J. Cu(I) Disrupts the Structure and Function of the Nonclassical Zinc Finger Protein Tristetraprolin (TTP). Inorg. Chem. 2017, 56, 6838–6848. [Google Scholar] [CrossRef] [Green Version]
- Doku, R.T.; Park, G.; Wheeler, K.E.; Splan, K.E. Spectroscopic characterization of copper(I) binding to apo and metal-reconstituted zinc finger peptides. J. Biol. Inorg. Chem. 2013, 18, 669–678. [Google Scholar] [CrossRef]
- Qin, X.; Huang, Q.; Zhu, L.; Xiao, H.; Yao, G.; Huang, W.; Zhu, R.; Hu, J.; Zhu, Y. Interaction with Cu(2)(+) disrupts the RNA binding affinities of RNA recognition motif containing protein. Biochem. Biophys. Res. Commun. 2014, 444, 116–120. [Google Scholar] [CrossRef]
- House, E.; Collingwood, J.; Khan, A.; Korchazkina, O.; Berthon, G.; Exley, C. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer’s disease. J. Alzheimers Dis. 2004, 6, 291–301. [Google Scholar] [CrossRef] [PubMed]
- Garzon-Rodriguez, W.; Yatsimirsky, A.K.; Glabe, C.G. Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer’s A beta peptide studied by fluorescence. Bioorganic Med. Chem. Lett. 1999, 9, 2243–2248. [Google Scholar] [CrossRef]
- Zou, J.; Kajita, K.; Sugimoto, N. Cu(2+) Inhibits the Aggregation of Amyloid beta-Peptide(1-42) in vitro We thank JEOL for the AFM measurement. This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Science, Sports, and Culture, and a Grant from “Research for the Future” Program of the Japan Society for the Promotion of Science to N.S. Angew. Chem. Int. Ed. Engl. 2001, 40, 2274–2277. [Google Scholar]
- Ward, B.; Walker, K.; Exley, C. Copper(II) inhibits the formation of amylin amyloid in vitro. J. Inorg. Biochem. 2008, 102, 371–375. [Google Scholar] [CrossRef] [PubMed]
- Khan, A.; Ashcroft, A.E.; Korchazhkina, O.V.; Exley, C. Metal-mediated formation of fibrillar ABri amyloid. J. Inorg. Biochem. 2004, 98, 2006–2010. [Google Scholar] [CrossRef]
- Lee, M.C.; Yu, W.C.; Shih, Y.H.; Chen, C.Y.; Guo, Z.H.; Huang, S.J.; Chan, J.C.C.; Chen, Y.R. Zinc ion rapidly induces toxic, off-pathway amyloid-beta oligomers distinct from amyloid-beta derived diffusible ligands in Alzheimer’s disease. Sci. Rep. 2018, 8, 4772. [Google Scholar] [CrossRef]
- Suzuki, K.; Miura, T.; Takeuchi, H. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide. Biochem. Biophys. Res. Commun. 2001, 285, 991–996. [Google Scholar] [CrossRef]
- Minicozzi, V.; Stellato, F.; Comai, M.; Dalla Serra, M.; Potrich, C.; Meyer-Klaucke, W.; Morante, S. Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides. J. Biol. Chem. 2008, 283, 10784–10792. [Google Scholar] [CrossRef] [Green Version]
- Brim, S.; Groschup, M.H.; Kuczius, T. Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes. PLoS ONE 2016, 11, e0153931. [Google Scholar] [CrossRef] [Green Version]
- Salzano, G.; Giachin, G.; Legname, G. Structural Consequences of Copper Binding to the Prion Protein. Cells 2019, 8, 770. [Google Scholar] [CrossRef] [Green Version]
- Wadsworth, J.D.; Hill, A.F.; Joiner, S.; Jackson, G.S.; Clarke, A.R.; Collinge, J. Strain-specific prion-protein conformation determined by metal ions. Nat. Cell Biol. 1999, 1, 55–59. [Google Scholar] [CrossRef]
- Qin, K.; Yang, D.S.; Yang, Y.; Chishti, M.A.; Meng, L.J.; Kretzschmar, H.A.; Yip, C.M.; Fraser, P.E.; Westaway, D. Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J. Biol. Chem. 2000, 275, 19121–19131. [Google Scholar] [CrossRef] [Green Version]
- Quaglio, E.; Chiesa, R.; Harris, D.A. Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J. Biol. Chem. 2001, 276, 11432–11438. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, Z.; Fernandez-Lima, F.A.; Russell, D.H. Amino acid influence on copper binding to peptides: Cysteine versus arginine. J. Am. Soc. Mass. Spectrom. 2010, 21, 522–533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maares, M.; Haase, H. Zinc and immunity: An essential interrelation. Arch. Biochem. Biophys. 2016, 611, 58–65. [Google Scholar] [CrossRef]
- Carcamo, C.; Hooton, T.; Weiss, N.S.; Gilman, R.; Wener, M.H.; Chavez, V.; Meneses, R.; Echevarria, J.; Vidal, M.; Holmes, K.K. Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HIV-1 infection. J. Acquir. Immune. Defic. Syndr. 2006, 43, 197–201. [Google Scholar] [CrossRef] [PubMed]
- Koch, J.; Neal, E.A.; Schlott, M.J.; Garcia-Shelton, Y.L.; Chan, M.F.; Weaver, K.E.; Cello, J.P. Serum zinc and protein levels: Lack of a correlation in hospitalized patients with AIDS. Nutrition 1996, 12, 511–514. [Google Scholar] [CrossRef]
- Visser, M.E.; Maartens, G.; Kossew, G.; Hussey, G.D. Plasma vitamin A and zinc levels in HIV-infected adults in Cape Town, South Africa. Br. J. Nutr. 2003, 89, 475–482. [Google Scholar] [CrossRef]
- Koch, J.; Neal, E.A.; Schlott, M.J.; Garcia-Shelton, Y.L.; Chan, M.F.; Weaver, K.E.; Cello, J.P. Zinc levels and infections in hospitalized patients with AIDS. Nutrition 1996, 12, 515–518. [Google Scholar] [CrossRef]
- Bunupuradah, T.; Ubolyam, S.; Hansudewechakul, R.; Kosalaraksa, P.; Ngampiyaskul, C.; Kanjanavanit, S.; Wongsawat, J.; Luesomboon, W.; Pinyakorn, S.; Kerr, S.; et al. Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms. Eur. J. Clin. Nutr. 2012, 66, 900–905. [Google Scholar] [CrossRef] [Green Version]
- Jones, C.Y.; Tang, A.M.; Forrester, J.E.; Huang, J.; Hendricks, K.M.; Knox, T.A.; Spiegelman, D.; Semba, R.D.; Woods, M.N. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J. Acquir. Immune Defic. Syndr. 2006, 43, 475–482. [Google Scholar] [CrossRef] [PubMed]
- Wellinghausen, N.; Kern, W.V.; Jochle, W.; Kern, P. Zinc serum level in human immunodeficiency virus-infected patients in relation to immunological status. Biol. Trace Elem. Res. 2000, 73, 139–149. [Google Scholar] [CrossRef]
- Cunningham-Rundles, S.; McNeeley, D.F.; Moon, A. Mechanisms of nutrient modulation of the immune response. J. Allergy Clin. Immunol. 2005, 115, 1119–1128. [Google Scholar] [CrossRef]
- Irlam, J.H.; Visser, M.M.; Rollins, N.N.; Siegfried, N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst. Rev. 2010. [Google Scholar] [CrossRef]
- Graham, N.M.; Sorensen, D.; Odaka, N.; Brookmeyer, R.; Chan, D.; Willett, W.C.; Morris, J.S.; Saah, A.J. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J. Acquir. Immune Defic. Syndr. 1991, 4, 976–980. [Google Scholar] [PubMed]
- Baum, M.K.; Campa, A.; Lai, S.; Lai, H.; Page, J.B. Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. Clin. Infect. Dis. 2003, 37 (Suppl. 2), S117–S123. [Google Scholar] [CrossRef]
- Fufa, H.; Umeta, M.; Taffesse, S.; Mokhtar, N.; Aguenaou, H. Nutritional and immunological status and their associations among HIV-infected adults in Addis Ababa, Ethiopia. Food Nutr. Bull. 2009, 30, 227–232. [Google Scholar] [CrossRef]
- Lai, H.; Lai, S.; Shor-Posner, G.; Ma, F.; Trapido, E.; Baum, M.K. Plasma zinc, copper, copper:zinc ratio, and survival in a cohort of HIV-1-infected homosexual men. J. Acquir. Immune Defic. Syndr. 2001, 27, 56–62. [Google Scholar] [CrossRef]
- Read, S.A.; Obeid, S.; Ahlenstiel, C.; Ahlenstiel, G. The Role of Zinc in Antiviral Immunity. Adv. Nutr. 2019, 10, 696–710. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baum, M.K.; Lai, S.; Sales, S.; Page, J.B.; Campa, A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin. Infect. Dis. 2010, 50, 1653–1660. [Google Scholar] [CrossRef] [PubMed]
- Mocchegiani, E.; Muzzioli, M.; Gaetti, R.; Veccia, S.; Viticchi, C.; Scalise, G. Contribution of zinc to reduce CD4+ risk factor for ‘severe’ infection relapse in aging: Parallelism with HIV. Int. J. Immunopharmacol. 1999, 21, 271–281. [Google Scholar] [CrossRef]
- Mocchegiani, E.; Veccia, S.; Ancarani, F.; Scalise, G.; Fabris, N. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int. J. Immunopharmacol. 1995, 17, 719–727. [Google Scholar] [CrossRef]
- Zeng, L.; Zhang, L. Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: Systematic review. Trop. Med. Int. Health 2011, 16, 1474–1482. [Google Scholar] [CrossRef] [PubMed]
- Lazarczyk, M.; Favre, M. Role of Zn2+ ions in host-virus interactions. J. Virol. 2008, 82, 11486–11494. [Google Scholar] [CrossRef] [Green Version]
- Darlix, J.L.; de Rocquigny, H.; Mauffret, O.; Mely, Y. Retrospective on the all-in-one retroviral nucleocapsid protein. Virus Res. 2014, 193, 2–15. [Google Scholar] [CrossRef] [Green Version]
- Lee, S.P.; Han, M.K. Zinc stimulates Mg2+-dependent 3′-processing activity of human immunodeficiency virus type 1 integrase in vitro. Biochemistry 1996, 35, 3837–3844. [Google Scholar] [CrossRef]
- Lee, S.P.; Xiao, J.; Knutson, J.R.; Lewis, M.S.; Han, M.K. Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 1997, 36, 173–180. [Google Scholar] [CrossRef]
- McEuen, A.R.; Edwards, B.; Koepke, K.A.; Ball, A.E.; Jennings, B.A.; Wolstenholme, A.J.; Danson, M.J.; Hough, D.W. Zinc binding by retroviral integrase. Biochem. Biophys. Res. Commun. 1992, 189, 813–818. [Google Scholar] [CrossRef]
- Frankel, A.D.; Chen, L.; Cotter, R.J.; Pabo, C.O. Dimerization of the tat protein from human immunodeficiency virus: A cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc. Natl. Acad. Sci. USA 1988, 85, 6297–6300. [Google Scholar] [CrossRef] [Green Version]
- Huang, H.W.; Wang, K.T. Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein. Biochem. Biophys. Res. Commun. 1996, 227, 615–621. [Google Scholar] [CrossRef] [PubMed]
- Garber, M.E.; Wei, P.; KewalRamani, V.N.; Mayall, T.P.; Herrmann, C.H.; Rice, A.P.; Littman, D.R.; Jones, K.A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 1998, 12, 3512–3527. [Google Scholar] [CrossRef] [Green Version]
- Luo, K.; Xiao, Z.; Ehrlich, E.; Yu, Y.; Liu, B.; Zheng, S.; Yu, X.F. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc. Natl. Acad. Sci. USA 2005, 102, 11444–11449. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Paul, I.; Cui, J.; Maynard, E.L. Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions. Proc. Natl. Acad. Sci. USA 2006, 103, 18475–18480. [Google Scholar] [CrossRef] [Green Version]
- Misumi, S.; Takamune, N.; Ohtsubo, Y.; Waniguchi, K.; Shoji, S. Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis. Aids Res. Hum. Retrovir. 2004, 20, 297–304. [Google Scholar] [CrossRef]
- Xiao, Z.; Ehrlich, E.; Luo, K.; Xiong, Y.; Yu, X.F. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. FASEB J. 2007, 21, 217–222. [Google Scholar] [CrossRef] [PubMed]
- Mori, M.; Kovalenko, L.; Lyonnais, S.; Antaki, D.; Torbett, B.E.; Botta, M.; Mirambeau, G.; Mely, Y. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1. Curr. Top. Microbiol. Immunol. 2015, 389, 53–92. [Google Scholar] [CrossRef] [PubMed]
- Goebel, F.D.; Hemmer, R.; Schmit, J.C.; Bogner, J.R.; de Clercq, E.; Witvrouw, M.; Pannecouque, C.; Valeyev, R.; Vandevelde, M.; Margery, H.; et al. Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy. AIDS 2001, 15, 33–45. [Google Scholar] [CrossRef] [PubMed]
- Rice, W.G.; Schaeffer, C.A.; Graham, L.; Bu, M.; McDougal, J.S.; Orloff, S.L.; Villinger, F.; Young, M.; Oroszlan, S.; Fesen, M.R.; et al. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Proc. Natl. Acad. Sci. USA 1993, 90, 9721–9724. [Google Scholar] [CrossRef] [Green Version]
- de Rocquigny, H.; Shvadchak, V.; Avilov, S.; Dong, C.Z.; Dietrich, U.; Darlix, J.L.; Mely, Y. Targeting the viral nucleocapsid protein in anti-HIV-1 therapy. Mini. Rev. Med. Chem. 2008, 8, 24–35. [Google Scholar]
- Musah, R.A. The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy. Curr. Top. Med. Chem. 2004, 4, 1605–1622. [Google Scholar] [CrossRef] [PubMed]
- Turpin, J.A.; Schito, M.L.; Jenkins, L.M.; Inman, J.K.; Appella, E. Topical microbicides: A promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors. Adv. Pharm. 2008, 56, 229–256. [Google Scholar] [CrossRef]
- Srivastava, P.; Schito, M.; Fattah, R.J.; Hara, T.; Hartman, T.; Buckheit, R.W., Jr.; Turpin, J.A.; Inman, J.K.; Appella, E. Optimization of unique, uncharged thioesters as inhibitors of HIV replication. Bioorganic Med. Chem. 2004, 12, 6437–6450. [Google Scholar] [CrossRef]
- Wallace, G.S.; Cheng-Mayer, C.; Schito, M.L.; Fletcher, P.; Miller Jenkins, L.M.; Hayashi, R.; Neurath, A.R.; Appella, E.; Shattock, R.J. Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection. J. Virol. 2009, 83, 9175–9182. [Google Scholar] [CrossRef] [Green Version]
- Vercruysse, T.; Basta, B.; Dehaen, W.; Humbert, N.; Balzarini, J.; Debaene, F.; Sanglier-Cianferani, S.; Pannecouque, C.; Mely, Y.; Daelemans, D. A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions. Retrovirology 2012, 9, 95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Breuer, S.; Chang, M.W.; Yuan, J.; Torbett, B.E. Identification of HIV-1 inhibitors targeting the nucleocapsid protein. J. Med. Chem. 2012, 55, 4968–4977. [Google Scholar] [CrossRef] [Green Version]
- Stephen, A.G.; Worthy, K.M.; Towler, E.; Mikovits, J.A.; Sei, S.; Roberts, P.; Yang, Q.E.; Akee, R.K.; Klausmeyer, P.; McCloud, T.G.; et al. Identification of HIV-1 nucleocapsid protein: Nucleic acid antagonists with cellular anti-HIV activity. Biochem. Biophys. Res. Commun. 2002, 296, 1228–1237. [Google Scholar] [CrossRef]
- Shvadchak, V.; Sanglier, S.; Rocle, S.; Villa, P.; Haiech, J.; Hibert, M.; Van Dorsselaer, A.; Mely, Y.; de Rocquigny, H. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein. Biochimie 2009, 91, 916–923. [Google Scholar] [CrossRef] [PubMed]
- Goudreau, N.; Hucke, O.; Faucher, A.M.; Grand-Maitre, C.; Lepage, O.; Bonneau, P.R.; Mason, S.W.; Titolo, S. Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometry. J. Mol. Biol. 2013, 425, 1982–1998. [Google Scholar] [CrossRef]
- Mori, M.; Schult-Dietrich, P.; Szafarowicz, B.; Humbert, N.; Debaene, F.; Sanglier-Cianferani, S.; Dietrich, U.; Mely, Y.; Botta, M. Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein. Virus Res. 2012, 169, 377–387. [Google Scholar] [CrossRef]
- Bernacchi, S.; Freisz, S.; Maechling, C.; Spiess, B.; Marquet, R.; Dumas, P.; Ennifar, E. Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: Thermodynamics and effect on the kissing-loop to duplex conversion. Nucleic Acids Res. 2007, 35, 7128–7139. [Google Scholar] [CrossRef]
- Pustowka, A.; Dietz, J.; Ferner, J.; Baumann, M.; Landersz, M.; Konigs, C.; Schwalbe, H.; Dietrich, U. Identification of peptide ligands for target RNA structures derived from the HIV-1 packaging signal psi by screening phage-displayed peptide libraries. Chembiochem 2003, 4, 1093–1097. [Google Scholar] [CrossRef]
- Warui, D.M.; Baranger, A.M. Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1. J. Med. Chem. 2009, 52, 5462–5473. [Google Scholar] [CrossRef] [PubMed]
- Raja, C.; Ferner, J.; Dietrich, U.; Avilov, S.; Ficheux, D.; Darlix, J.L.; de Rocquigny, H.; Schwalbe, H.; Mely, Y. A tryptophan-rich hexapeptide inhibits nucleic acid destabilization chaperoned by the HIV-1 nucleocapsid protein. Biochemistry 2006, 45, 9254–9265. [Google Scholar] [CrossRef]
- Cabot, C.; Martos, S.; Llugany, M.; Gallego, B.; Tolra, R.; Poschenrieder, C. A Role for Zinc in Plant Defense against Pathogens and Herbivores. Front. Plant. Sci. 2019, 10, 1171. [Google Scholar] [CrossRef] [PubMed]
- Morina, F.; Mishra, A.; Mijovilovich, A.; Matouskova, S.; Bruckner, D.; Spak, J.; Kupper, H. Interaction Between Zn Deficiency, Toxicity and Turnip Yellow Mosaic Virus Infection in Noccaea ochroleucum. Front. Plant. Sci. 2020, 11, 739. [Google Scholar] [CrossRef]
- Helms, K.; Pound, G.S. Zinc nutrition of Nicotiana tabacum L. in relation to multiplication of tobacco mosaic virus. Virology 1955, 1, 408–423. [Google Scholar] [CrossRef]
- Korant, B.D.; Kauer, J.C.; Butterworth, B.E. Zinc ions inhibit replication of rhinoviruses. Nature 1974, 248, 588–590. [Google Scholar] [CrossRef]
- Warnes, S.L.; Summersgill, E.N.; Keevil, C.W. Inactivation of murine norovirus on a range of copper alloy surfaces is accompanied by loss of capsid integrity. Appl. Environ. Microbiol. 2015, 81, 1085–1091. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kaushik, N.; Subramani, C.; Anang, S.; Muthumohan, R.; Shalimar; Nayak, B.; Ranjith-Kumar, C.T.; Surjit, M. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase. J. Virol. 2017, 91. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- te Velthuis, A.J.; van den Worm, S.H.; Sims, A.C.; Baric, R.S.; Snijder, E.J.; van Hemert, M.J. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010, 6, e1001176. [Google Scholar] [CrossRef]
- Fenstermacher, K.J.; DeStefano, J.J. Mechanism of HIV reverse transcriptase inhibition by zinc: Formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity. J. Biol. Chem. 2011, 286, 40433–40442. [Google Scholar] [CrossRef] [Green Version]
- Rukgauer, M.; Klein, J.; Kruse-Jarres, J.D. Reference values for the trace elements copper, manganese, selenium, and zinc in the serum/plasma of children, adolescents, and adults. J. Trace Elem. Med. Biol. 1997, 11, 92–98. [Google Scholar] [CrossRef]
- Kumel, G.; Schrader, S.; Zentgraf, H.; Daus, H.; Brendel, M. The mechanism of the antiherpetic activity of zinc sulphate. J. Gen. Virol. 1990, 71, 2989–2997. [Google Scholar] [CrossRef]
- Ghaffari, H.; Tavakoli, A.; Moradi, A.; Tabarraei, A.; Bokharaei-Salim, F.; Zahmatkeshan, M.; Farahmand, M.; Javanmard, D.; Kiani, S.J.; Esghaei, M.; et al. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: Another emerging application of nanomedicine. J. Biomed. Sci. 2019, 26, 70. [Google Scholar] [CrossRef]
- Tavakoli, A.; Ataei-Pirkooh, A.; Mm Sadeghi, G.; Bokharaei-Salim, F.; Sahrapour, P.; Kiani, S.J.; Moghoofei, M.; Farahmand, M.; Javanmard, D.; Monavari, S.H. Polyethylene glycol-coated zinc oxide nanoparticle: An efficient nanoweapon to fight against herpes simplex virus type 1. Nanomedicine 2018, 13, 2675–2690. [Google Scholar] [CrossRef]
- Beerheide, W.; Bernard, H.U.; Tan, Y.J.; Ganesan, A.; Rice, W.G.; Ting, A.E. Potential drugs against cervical cancer: Zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J. Natl. Cancer Inst. 1999, 91, 1211–1220. [Google Scholar] [CrossRef] [Green Version]
- Li, X.D.; Shan, C.; Deng, C.L.; Ye, H.Q.; Shi, P.Y.; Yuan, Z.M.; Gong, P.; Zhang, B. The interface between methyltransferase and polymerase of NS5 is essential for flavivirus replication. PLoS Negl. Trop. Dis. 2014, 8, e2891. [Google Scholar] [CrossRef]
- Dubankova, A.; Boura, E. Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses. Antivir. Res. 2019, 169, 104536. [Google Scholar] [CrossRef]
- Kar, M.; Khan, N.A.; Panwar, A.; Bais, S.S.; Basak, S.; Goel, R.; Sopory, S.; Medigeshi, G.R. Zinc Chelation Specifically Inhibits Early Stages of Dengue Virus Replication by Activation of NF-kappaB and Induction of Antiviral Response in Epithelial Cells. Front. Immunol. 2019, 10, 2347. [Google Scholar] [CrossRef]
- Kesel, A.J. A system of protein target sequences for anti-RNA-viral chemotherapy by a vitamin B6-derived zinc-chelating trioxa-adamantane-triol. Bioorganic Med. Chem. 2003, 11, 4599–4613. [Google Scholar] [CrossRef]
- Tanner, J.A.; Zheng, B.J.; Zhou, J.; Watt, R.M.; Jiang, J.Q.; Wong, K.L.; Lin, Y.P.; Lu, L.Y.; He, M.L.; Kung, H.F.; et al. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem. Biol. 2005, 12, 303–311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xue, J.; Moyer, A.; Peng, B.; Wu, J.; Hannafon, B.N.; Ding, W.Q. Chloroquine is a zinc ionophore. PLoS ONE 2014, 9, e109180. [Google Scholar] [CrossRef] [Green Version]
- Rodrigo, C.; Fernando, S.D.; Rajapakse, S. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: A systematic review. Clin. Microbiol. Infect. 2020. [Google Scholar] [CrossRef] [PubMed]
- Babula, P.; Masarik, M.; Adam, V.; Eckschlager, T.; Stiborova, M.; Trnkova, L.; Skutkova, H.; Provaznik, I.; Hubalek, J.; Kizek, R. Mammalian metallothioneins: Properties and functions. Metallomics 2012, 4, 739–750. [Google Scholar] [CrossRef] [PubMed]
- Ruttkay-Nedecky, B.; Jimenez Jimenez, A.M.; Nejdl, L.; Chudobova, D.; Gumulec, J.; Masarik, M.; Adam, V.; Kizek, R. Relevance of infection with human papillomavirus: The role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (Review). Int. J. Oncol. 2013, 43, 1754–1762. [Google Scholar] [CrossRef] [Green Version]
- Tomaic, V. Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites. Cancers 2016, 8, 95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nees, M.; Geoghegan, J.M.; Munson, P.; Prabhu, V.; Liu, Y.; Androphy, E.; Woodworth, C.D. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Cancer Res. 2000, 60, 4289–4298. [Google Scholar]
- Alonso, L.G.; Garcia-Alai, M.M.; Smal, C.; Centeno, J.M.; Iacono, R.; Castano, E.; Gualfetti, P.; de Prat-Gay, G. The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers. Biochemistry 2004, 43, 3310–3317. [Google Scholar] [CrossRef]
- Smal, C.; Alonso, L.G.; Wetzler, D.E.; Heer, A.; de Prat Gay, G. Ordered self-assembly mechanism of a spherical oncoprotein oligomer triggered by zinc removal and stabilized by an intrinsically disordered domain. PLoS ONE 2012, 7, e36457. [Google Scholar] [CrossRef] [Green Version]
- Roth, E.J.; Kurz, B.; Liang, L.; Hansen, C.L.; Dameron, C.T.; Winge, D.R.; Smotkin, D. Metal thiolate coordination in the E7 proteins of human papilloma virus 16 and cottontail rabbit papilloma virus as expressed in Escherichia coli. J. Biol. Chem. 1992, 267, 16390–16395. [Google Scholar] [PubMed]
- Kumar, A.; Kuhn, L.T.; Balbach, J. A Cu(2+) complex induces the aggregation of human papillomavirus oncoprotein E6 and stabilizes p53. FEBS J. 2018, 285, 3013–3025. [Google Scholar] [CrossRef]
- Quiroz, F.G.; Fiore, V.F.; Levorse, J.; Polak, L.; Wong, E.; Pasolli, H.A.; Fuchs, E. Liquid-liquid phase separation drives skin barrier formation. Science 2020, 367. [Google Scholar] [CrossRef] [PubMed]
- Ogawa, Y.; Kinoshita, M.; Shimada, S.; Kawamura, T. Zinc in Keratinocytes and Langerhans Cells: Relevance to the Epidermal Homeostasis. J. Immunol. Res. 2018, 2018, 5404093. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garcia, C.C.; Ellenberg, P.C.; Artuso, M.C.; Scolaro, L.A.; Damonte, E.B. Characterization of Junin virus particles inactivated by a zinc finger-reactive compound. Virus Res. 2009, 143, 106–113. [Google Scholar] [CrossRef] [PubMed]
- Okada, A.; Miura, T.; Takeuchi, H. Zinc- and pH-dependent conformational transition in a putative interdomain linker region of the influenza virus matrix protein M1. Biochemistry 2003, 42, 1978–1984. [Google Scholar] [CrossRef]
- Ratka, M.; Lackmann, M.; Ueckermann, C.; Karlins, U.; Koch, G. Poliovirus-associated protein kinase: Destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+. J. Virol. 1989, 63, 3954–3960. [Google Scholar] [CrossRef] [Green Version]
- Hodek, J.; Zajicova, V.; Lovetinska-Slamborova, I.; Stibor, I.; Mullerova, J.; Weber, J. Protective hybrid coating containing silver, copper and zinc cations effective against human immunodeficiency virus and other enveloped viruses. BMC Microbiol. 2016, 16 (Suppl. 1), 56. [Google Scholar] [CrossRef] [Green Version]
- Han, J.; Chen, L.; Duan, S.M.; Yang, Q.X.; Yang, M.; Gao, C.; Zhang, B.Y.; He, H.; Dong, X.P. Efficient and quick inactivation of SARS coronavirus and other microbes exposed to the surfaces of some metal catalysts. Biomed. Environ. Sci. 2005, 18, 176–180. [Google Scholar]
- Warnes, S.L.; Little, Z.R.; Keevil, C.W. Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials. mBio 2015, 6. [Google Scholar] [CrossRef] [Green Version]
- Manuel, C.S.; Moore, M.D.; Jaykus, L.A. Destruction of the Capsid and Genome of GII.4 Human Norovirus Occurs during Exposure to Metal Alloys Containing Copper. Appl. Environ. Microbiol. 2015, 81, 4940–4946. [Google Scholar] [CrossRef] [Green Version]
- Jung, J.; Grant, T.; Thomas, D.R.; Diehnelt, C.W.; Grigorieff, N.; Joshua-Tor, L. High-resolution cryo-EM structures of outbreak strain human norovirus shells reveal size variations. Proc. Natl. Acad. Sci. USA 2019, 116, 12828–12832. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Luo, H.; Chen, J.; Chen, K.; Shen, X.; Jiang, H. Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: Self-association analysis and nucleic acid binding characterization. Biochemistry 2006, 45, 11827–11835. [Google Scholar] [CrossRef] [PubMed]
- Cai, Y.; Zhang, J.; Xiao, T.; Peng, H.; Sterling, S.M.; Walsh, R.M.; Rawson, S.; Rits-Volloch, S.; Chen, B. Distinct conformational states of SARS-CoV-2 spike protein. BioRxiv 2020. [Google Scholar] [CrossRef]
- Petit, C.M.; Chouljenko, V.N.; Iyer, A.; Colgrove, R.; Farzan, M.; Knipe, D.M.; Kousoulas, K.G. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. Virology 2007, 360, 264–274. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Elrashdy, F.; Redwan, E.M.; Uversky, V.N. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2. Infect. Genet. Evol. 2020, 85, 104510. [Google Scholar] [CrossRef]
- Borkow, G.; Gabbay, J. Copper as a biocidal tool. Curr. Med. Chem. 2005, 12, 2163–2175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Scholefield, H. Best Practice and Research Clinical Obstetrics and Gynaecology. Preface. Best Pr. Res. Clin. Obs. Gynaecol. 2008, 22, 761–762. [Google Scholar] [CrossRef]
- Hostynek, J.J.; Maibach, H.I. Copper hypersensitivity: Dermatologic aspects--an overview. Rev. Environ. Health 2003, 18, 153–183. [Google Scholar] [CrossRef]
- Castellsague, X.; Diaz, M.; Vaccarella, S.; de Sanjose, S.; Munoz, N.; Herrero, R.; Franceschi, S.; Meijer, C.J.; Bosch, F.X. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: A pooled analysis of 26 epidemiological studies. Lancet Oncol. 2011, 12, 1023–1031. [Google Scholar] [CrossRef]
- Yamamoto, N.; Hiatt, C.W.; Haller, W. Mechanism of Inactivation of Bacteriophages by Metals. Biochim. Biophys. Acta 1964, 91, 257–261. [Google Scholar] [CrossRef]
- Jordan, F.T.; Nassar, T.J. The influence of copper on the survival of infectious bronchitis vaccine virus in water. Vet. Rec. 1971, 89, 609–610. [Google Scholar] [CrossRef] [PubMed]
- Totsuka, A.; Otaki, K. The effects of amino acids and metals on the infectivity of poliovirus ribonucleic acid. JPN J. Microbiol. 1974, 18, 107–112. [Google Scholar] [CrossRef] [PubMed]
- Sagripanti, J.L. Metal-based formulations with high microbicidal activity. Appl. Environ. Microbiol. 1992, 58, 3157–3162. [Google Scholar] [CrossRef] [Green Version]
- Sagripanti, J.L.; Routson, L.B.; Lytle, C.D. Virus inactivation by copper or iron ions alone and in the presence of peroxide. Appl. Environ. Microbiol. 1993, 59, 4374–4376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sagripanti, J.L.; Lightfoote, M.M. Cupric and ferric ions inactivate HIV. Aids Res. Hum. Retrovir. 1996, 12, 333–337. [Google Scholar] [CrossRef]
- Yu, X.; Hathout, Y.; Fenselau, C.; Sowder, R.C., II; Henderson, L.E.; Rice, W.G.; Mendeleyev, J.; Kun, E. Specific disulfide formation in the oxidation of HIV-1 zinc finger protein nucleocapsid p7. Chem. Res. Toxicol. 1995, 8, 586–590. [Google Scholar] [CrossRef]
- Borkow, G.; Gabbay, J. Putting copper into action: Copper-impregnated products with potent biocidal activities. FASEB J. 2004, 18, 1728–1730. [Google Scholar] [CrossRef]
- Borkow, G.; Lara, H.H.; Covington, C.Y.; Nyamathi, A.; Gabbay, J. Deactivation of human immunodeficiency virus type 1 in medium by copper oxide-containing filters. Antimicrob. Agents Chemother. 2008, 52, 518–525. [Google Scholar] [CrossRef] [Green Version]
- Borkow, G.; Sidwell, R.W.; Smee, D.F.; Barnard, D.L.; Morrey, J.D.; Lara-Villegas, H.H.; Shemer-Avni, Y.; Gabbay, J. Neutralizing viruses in suspensions by copper oxide-based filters. Antimicrob. Agents Chemother. 2007, 51, 2605–2607. [Google Scholar] [CrossRef] [Green Version]
- Abad, F.X.; Pinto, R.M.; Diez, J.M.; Bosch, A. Disinfection of human enteric viruses in water by copper and silver in combination with low levels of chlorine. Appl. Environ. Microbiol. 1994, 60, 2377–2383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pierpoint, W.S.; Harrison, B.D. Copper-Dependent and Iron-Dependent Inactivations of Cucumber Mosaic Virus by Polyphenols. J. Gen. Microbiol. 1963, 32, 429–440. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sportelli, M.C.; Izzi, M.; Kukushkina, E.A.; Hossain, S.I.; Picca, R.A.; Ditaranto, N.; Cioffi, N. Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2? Nanomaterials 2020, 10, 802. [Google Scholar] [CrossRef] [Green Version]
- Casey, A.L.; Adams, D.; Karpanen, T.J.; Lambert, P.A.; Cookson, B.D.; Nightingale, P.; Miruszenko, L.; Shillam, R.; Christian, P.; Elliott, T.S. Role of copper in reducing hospital environment contamination. J. Hosp. Infect. 2010, 74, 72–77. [Google Scholar] [CrossRef] [PubMed]
- Karpanen, T.J.; Casey, A.L.; Lambert, P.A.; Cookson, B.D.; Nightingale, P.; Miruszenko, L.; Elliott, T.S. The antimicrobial efficacy of copper alloy furnishing in the clinical environment: A crossover study. Infect. Control. Hosp. Epidemiol. 2012, 33, 3–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schmidt, M.G.; Attaway, H.H.; Sharpe, P.A.; John, J., Jr.; Sepkowitz, K.A.; Morgan, A.; Fairey, S.E.; Singh, S.; Steed, L.L.; Cantey, J.R.; et al. Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J. Clin. Microbiol. 2012, 50, 2217–2223. [Google Scholar] [CrossRef] [Green Version]
- Salgado, C.D.; Sepkowitz, K.A.; John, J.F.; Cantey, J.R.; Attaway, H.H.; Freeman, K.D.; Sharpe, P.A.; Michels, H.T.; Schmidt, M.G. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect. Control. Hosp. Epidemiol. 2013, 34, 479–486. [Google Scholar] [CrossRef] [Green Version]
- Mantlo, E.; Paessler, S.; Seregin, A.V.; Mitchell, A.T. Luminore CopperTouch surface coating effectively inactivates SARS-CoV-2, Ebola and Marburg viruses in vitro. MedRxiv 2020. [Google Scholar] [CrossRef]
- Borkow, G.; Zhou, S.S.; Page, T.; Gabbay, J. A novel anti-influenza copper oxide containing respiratory face mask. PLoS ONE 2010, 5, e11295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Noyce, J.O.; Michels, H.; Keevil, C.W. Inactivation of influenza a virus on copper versus stainless steel surfaces. Appl. Environ. Microbiol. 2007, 73, 2748–2750. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McCord, J.M.; Fridovich, I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244, 6049–6055. [Google Scholar]
- Kaur, S.J.; McKeown, S.R.; Rashid, S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene 2016, 577, 109–118. [Google Scholar] [CrossRef] [PubMed]
- Grad, L.I.; Pokrishevsky, E.; Cashman, N.R. Intercellular Prion-Like Conversion and Transmission of Cu/Zn Superoxide Dismutase (SOD1) in Cell Culture. Methods Mol. Biol. 2017, 1658, 357–367. [Google Scholar] [CrossRef] [PubMed]
- Teoh, M.L.; Walasek, P.J.; Evans, D.H. Leporipoxvirus Cu, Zn-superoxide dismutase (SOD) homologs are catalytically inert decoy proteins that bind copper chaperone for SOD. J. Biol. Chem. 2003, 278, 33175–33184. [Google Scholar] [CrossRef] [Green Version]
- Bawden, A.L.; Glassberg, K.J.; Diggans, J.; Shaw, R.; Farmerie, W.; Moyer, R.W. Complete genomic sequence of the Amsacta moorei entomopoxvirus: Analysis and comparison with other poxviruses. Virology 2000, 274, 120–139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tomalski, M.D.; Eldridge, R.; Miller, L.K. A baculovirus homolog of a Cu/Zn superoxide dismutase gene. Virology 1991, 184, 149–161. [Google Scholar] [CrossRef]
- Smith, G.L.; Chan, Y.S.; Howard, S.T. Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J. Gen. Virol. 1991, 72, 1349–1376. [Google Scholar] [CrossRef]
- Cao, J.X.; Teoh, M.L.; Moon, M.; McFadden, G.; Evans, D.H. Leporipoxvirus Cu-Zn superoxide dismutase homologs inhibit cellular superoxide dismutase, but are not essential for virus replication or virulence. Virology 2002, 296, 125–135. [Google Scholar] [CrossRef] [Green Version]
- Hosakote, Y.M.; Liu, T.; Castro, S.M.; Garofalo, R.P.; Casola, A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am. J. Respir. Cell Mol. Biol. 2009, 41, 348–357. [Google Scholar] [CrossRef]
- Pyo, C.W.; Shin, N.; Jung, K.I.; Choi, J.H.; Choi, S.Y. Alteration of copper-zinc superoxide dismutase 1 expression by influenza A virus is correlated with virus replication. Biochem. Biophys. Res. Commun. 2014, 450, 711–716. [Google Scholar] [CrossRef]
- Fu, S.; Shao, J.; Zhou, C.; Hartung, J.S. Co-infection of Sweet Orange with Severe and Mild Strains of Citrus tristeza virus Is Overwhelmingly Dominated by the Severe Strain on Both the Transcriptional and Biological Levels. Front. Plant. Sci. 2017, 8, 1419. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, F.; Naylor, S.L.; Lum, J.B.; Cutshaw, S.; McCombs, J.L.; Naberhaus, K.H.; McGill, J.R.; Adrian, G.S.; Moore, C.M.; Barnett, D.R.; et al. Characterization, mapping, and expression of the human ceruloplasmin gene. Proc. Natl. Acad. Sci. USA 1986, 83, 3257–3261. [Google Scholar] [CrossRef] [Green Version]
- Sato, M.; Gitlin, J.D. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem. 1991, 266, 5128–5134. [Google Scholar] [PubMed]
- Hirano, K.; Ogihara, T.; Ogihara, H.; Hiroi, M.; Hasegawa, M.; Tamai, H. Identification of apo- and holo-forms of ceruloplasmin in patients with Wilson’s disease using native polyacrylamide gel electrophoresis. Clin. Biochem. 2005, 38, 9–12. [Google Scholar] [CrossRef]
- Middleton, R.B.; Linder, M.C. Synthesis and turnover of ceruloplasmin in rats treated with 17 beta-estradiol. Arch. Biochem. Biophys. 1993, 302, 362–368. [Google Scholar] [CrossRef] [PubMed]
- Ramos, D.; Mar, D.; Ishida, M.; Vargas, R.; Gaite, M.; Montgomery, A.; Linder, M.C. Mechanism of Copper Uptake from Blood Plasma Ceruloplasmin by Mammalian Cells. PLoS ONE 2016, 11, e0149516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Linder, M.C. Ceruloplasmin and other copper binding components of blood plasma and their functions: An update. Metallomics 2016, 8, 887–905. [Google Scholar] [CrossRef]
- Cernat, R.I.; Mihaescu, T.; Vornicu, M.; Vione, D.; Olariu, R.I.; Arsene, C. Serum trace metal and ceruloplasmin variability in individuals treated for pulmonary tuberculosis. Int. J. Tuberc. Lung. Dis. 2011, 15, 1239–1245. [Google Scholar] [CrossRef]
- Li, C.X.; Gleason, J.E.; Zhang, S.X.; Bruno, V.M.; Cormack, B.P.; Culotta, V.C. Candida albicans adapts to host copper during infection by swapping metal cofactors for superoxide dismutase. Proc. Natl. Acad. Sci. USA 2015, 112, E5336–E5342. [Google Scholar] [CrossRef] [Green Version]
- Milanino, R.; Buchner, V. Copper: Role of the ‘endogenous’ and ‘exogenous’ metal on the development and control of inflammatory processes. Rev. Environ. Health 2006, 21, 153–215. [Google Scholar] [CrossRef]
- Besold, A.N.; Culbertson, E.M.; Culotta, V.C. The Yin and Yang of copper during infection. J. Biol. Inorg. Chem. 2016, 21, 137–144. [Google Scholar] [CrossRef]
- Zhao, K.; Wu, C.; Yao, Y.; Cao, L.; Zhang, Z.; Yuan, Y.; Wang, Y.; Pei, R.; Chen, J.; Hu, X.; et al. Ceruloplasmin inhibits the production of extracellular hepatitis B virions by targeting its middle surface protein. J. Gen. Virol. 2017, 98, 1410–1421. [Google Scholar] [CrossRef] [PubMed]
- Novikova, I.; Zlotnikova, M. Ceruloplasmin plasma levels in patients with severe forms of herpes infection. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 2011, 155, 361–366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kallianpur, A.R.; Gittleman, H.; Letendre, S.; Ellis, R.; Barnholtz-Sloan, J.S.; Bush, W.S.; Heaton, R.; Samuels, D.C.; Franklin, D.R., Jr.; Rosario-Cookson, D.; et al. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. Mol. Neurobiol. 2019, 56, 3808–3818. [Google Scholar] [CrossRef]
- Rozek, W.; Horning, J.; Anderson, J.; Ciborowski, P. Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment. Proteom. Clin. Appl. 2008, 2, 1498–1507. [Google Scholar] [CrossRef] [Green Version]
- Conti, A.; Iannaccone, S.; Sferrazza, B.; De Monte, L.; Cappa, S.; Franciotta, D.; Olivieri, S.; Alessio, M. Differential expression of ceruloplasmin isoforms in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Proteom. Clin. Appl. 2008, 2, 1628–1637. [Google Scholar] [CrossRef] [PubMed]
- Diouf, I.; Bush, A.I.; Ayton, S.; Alzheimer’s disease Neuroimaging, I. Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying beta-amyloid pathology. Neurobiol. Dis. 2020, 139, 104810. [Google Scholar] [CrossRef]
- Wang, B.; Wang, X.P. Does Ceruloplasmin Defend Against Neurodegenerative Diseases? Curr. Neuropharmacol. 2019, 17, 539–549. [Google Scholar] [CrossRef]
- Bogden, J.D.; Baker, H.; Frank, O.; Perez, G.; Kemp, F.; Bruening, K.; Louria, D. Micronutrient status and human immunodeficiency virus (HIV) infection. Ann. N. Y. Acad. Sci. 1990, 587, 189–195. [Google Scholar] [CrossRef]
- Guo, C.H.; Chen, P.C.; Yeh, M.S.; Hsiung, D.Y.; Wang, C.L. Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin. Biochem. 2011, 44, 275–280. [Google Scholar] [CrossRef]
- Leone, N.; Courbon, D.; Ducimetiere, P.; Zureik, M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 2006, 17, 308–314. [Google Scholar] [CrossRef] [PubMed]
- Malavolta, M.; Piacenza, F.; Basso, A.; Giacconi, R.; Costarelli, L.; Mocchegiani, E. Serum copper to zinc ratio: Relationship with aging and health status. Mech. Ageing Dev. 2015, 151, 93–100. [Google Scholar] [CrossRef] [PubMed]
- Gaier, E.D.; Kleppinger, A.; Ralle, M.; Mains, R.E.; Kenny, A.M.; Eipper, B.A. High serum Cu and Cu/Zn ratios correlate with impairments in bone density, physical performance and overall health in a population of elderly men with frailty characteristics. Exp. Gerontol. 2012, 47, 491–496. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Karahan, S.C.; Deger, O.; Orem, A.; Ucar, F.; Erem, C.; Alver, A.; Onder, E. The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus. Clin. Chem. Lab. Med. 2001, 39, 109–115. [Google Scholar] [CrossRef] [PubMed]
- Oyama, T.; Matsuno, K.; Kawamoto, T.; Mitsudomi, T.; Shirakusa, T.; Kodama, Y. Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer. Biol. Trace Elem. Res. 1994, 42, 115–127. [Google Scholar] [CrossRef]
- Donma, M.M.; Donma, O.; Tas, M.A. Hair zinc and copper concentrations and zinc: Copper ratios in pediatric malignancies and healthy children from southeastern Turkey. Biol. Trace Elem. Res. 1993, 36, 51–63. [Google Scholar] [CrossRef]
- Luterotti, S.; Kordic, T.V.; Letoja, I.Z.; Dodig, S. Contribution to diagnostics/prognostics of tuberculosis in children. II. Indicative value of metal ions and biochemical parameters in serum. Acta Pharm. 2015, 65, 321–329. [Google Scholar] [CrossRef] [Green Version]
- Wisniewska, M.; Cremer, M.; Wiehe, L.; Becker, N.P.; Rijntjes, E.; Martitz, J.; Renko, K.; Buhrer, C.; Schomburg, L. Copper to Zinc Ratio as Disease Biomarker in Neonates with Early-Onset Congenital Infections. Nutrients 2017, 9, 343. [Google Scholar] [CrossRef] [Green Version]
- Guo, C.H.; Wang, C.L. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int. J. Med. Sci. 2013, 10, 79–89. [Google Scholar] [CrossRef] [Green Version]
- Asemota, E.A.; Okafor, I.M.; Okoroiwu, H.U.; Ekong, E.R.; Anyanwu, S.O.; Efiong, E.E.; Udomah, F. Zinc, copper, CD4 T-cell count and some hematological parameters of HIV-infected subjects in Southern Nigeria. Integr. Med. Res. 2018, 7, 53–60. [Google Scholar] [CrossRef]
- Kassu, A.; Yabutani, T.; Mahmud, Z.H.; Mohammad, A.; Nguyen, N.; Huong, B.T.; Hailemariam, G.; Diro, E.; Ayele, B.; Wondmikun, Y.; et al. Alterations in serum levels of trace elements in tuberculosis and HIV infections. Eur. J. Clin. Nutr. 2006, 60, 580–586. [Google Scholar] [CrossRef] [Green Version]
- Abolbashari, S.; Darroudi, S.; Tayefi, M.; Khashyarmaneh, Z.; Zamani, P.; Haghighi, H.M.; Mohammadpour, A.H.; Tavalaei, S.; Ahmadnezhad, M.; Esmaily, H.; et al. Association between serum zinc and copper levels and antioxidant defense in subjects infected with human T-lymphotropic virus type 1. J. Blood Med. 2019, 10, 29–35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jones, C.E.; Abdelraheim, S.R.; Brown, D.R.; Viles, J.H. Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. J. Biol. Chem. 2004, 279, 32018–32027. [Google Scholar] [CrossRef] [Green Version]
- Lathe, R.; Darlix, J.L. Prion Protein PRNP: A New Player in Innate Immunity? The Abeta Connection. J. Alzheimers Dis. Rep. 2017, 1, 263–275. [Google Scholar] [CrossRef] [Green Version]
- Jenssen, H.; Hamill, P.; Hancock, R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19, 491–511. [Google Scholar] [CrossRef] [Green Version]
- Kumar, D.K.; Choi, S.H.; Washicosky, K.J.; Eimer, W.A.; Tucker, S.; Ghofrani, J.; Lefkowitz, A.; McColl, G.; Goldstein, L.E.; Tanzi, R.E.; et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci. Transl. Med. 2016, 8, 340ra372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lotscher, M.; Recher, M.; Hunziker, L.; Klein, M.A. Immunologically induced, complement-dependent up-regulation of the prion protein in the mouse spleen: Follicular dendritic cells versus capsule and trabeculae. J. Immunol. 2003, 170, 6040–6047. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Piersanti, S.; Martina, Y.; Cherubini, G.; Avitabile, D.; Saggio, I. Use of DNA microarrays to monitor host response to virus and virus-derived gene therapy vectors. Am. J. Pharm. 2004, 4, 345–356. [Google Scholar] [CrossRef] [PubMed]
- Walters, K.A.; Joyce, M.A.; Thompson, J.C.; Smith, M.W.; Yeh, M.M.; Proll, S.; Zhu, L.F.; Gao, T.J.; Kneteman, N.M.; Tyrrell, D.L.; et al. Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: Role of the innate antiviral immune response. PLoS Pathog. 2006, 2, e59. [Google Scholar] [CrossRef]
- Muller, W.E.; Pfeifer, K.; Forrest, J.; Rytik, P.G.; Eremin, V.F.; Popov, S.A.; Schroder, H.C. Accumulation of transcripts coding for prion protein in human astrocytes during infection with human immunodeficiency virus. Biochim. Biophys. Acta 1992, 1139, 32–40. [Google Scholar] [CrossRef]
- Yuan, J.; Cahir-McFarland, E.; Zhao, B.; Kieff, E. Virus and cell RNAs expressed during Epstein-Barr virus replication. J. Virol. 2006, 80, 2548–2565. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Roberts, T.K.; Eugenin, E.A.; Morgello, S.; Clements, J.E.; Zink, M.C.; Berman, J.W. PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am. J. Pathol. 2010, 177, 1848–1860. [Google Scholar] [CrossRef] [PubMed]
- Voigtlander, T.; Kloppel, S.; Birner, P.; Jarius, C.; Flicker, H.; Verghese-Nikolakaki, S.; Sklaviadis, T.; Guentchev, M.; Budka, H. Marked increase of neuronal prion protein immunoreactivity in Alzheimer’s disease and human prion diseases. Acta Neuropathol. 2001, 101, 417–423. [Google Scholar] [CrossRef] [PubMed]
- Itzhaki, R.F.; Lathe, R.; Balin, B.J.; Ball, M.J.; Bearer, E.L.; Braak, H.; Bullido, M.J.; Carter, C.; Clerici, M.; Cosby, S.L.; et al. Microbes and Alzheimer’s Disease. J. Alzheimers Dis. 2016, 51, 979–984. [Google Scholar] [CrossRef] [Green Version]
- Leblanc, P.; Baas, D.; Darlix, J.L. Analysis of the interactions between HIV-1 and the cellular prion protein in a human cell line. J. Mol. Biol. 2004, 337, 1035–1051. [Google Scholar] [CrossRef] [PubMed]
- Hoogenraad, T.U. Paradigm shift in treatment of Alzheimer’s disease: Zinc therapy now a conscientious choice for care of individual patients. Int. J. Alzheimers Dis. 2011, 2011, 492686. [Google Scholar] [CrossRef] [Green Version]
- Ilback, N.G.; Glynn, A.W.; Wikberg, L.; Netzel, E.; Lindh, U. Metallothionein is induced and trace element balance changed in target organs of a common viral infection. Toxicology 2004, 199, 241–250. [Google Scholar] [CrossRef] [PubMed]
- Zilliox, M.J.; Parmigiani, G.; Griffin, D.E. Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc. Natl. Acad. Sci. USA 2006, 103, 3363–3368. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mindaye, S.T.; Ilyushina, N.A.; Fantoni, G.; Alterman, M.A.; Donnelly, R.P.; Eichelberger, M.C. Impact of Influenza A Virus Infection on the Proteomes of Human Bronchoepithelial Cells from Different Donors. J. Proteome Res. 2017, 16, 3287–3297. [Google Scholar] [CrossRef] [Green Version]
- Raymond, A.D.; Gekonge, B.; Giri, M.S.; Hancock, A.; Papasavvas, E.; Chehimi, J.; Kossenkov, A.V.; Nicols, C.; Yousef, M.; Mounzer, K.; et al. Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia. J. Leukoc. Biol. 2010, 88, 589–596. [Google Scholar] [CrossRef] [Green Version]
- Read, S.A.; Parnell, G.; Booth, D.; Douglas, M.W.; George, J.; Ahlenstiel, G. The antiviral role of zinc and metallothioneins in hepatitis C infection. J. Viral Hepat. 2018, 25, 491–501. [Google Scholar] [CrossRef] [PubMed]
- Izmailova, E.; Bertley, F.M.; Huang, Q.; Makori, N.; Miller, C.J.; Young, R.A.; Aldovini, A. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat. Med. 2003, 9, 191–197. [Google Scholar] [CrossRef] [PubMed]
- Fernandez, J.; Portilho, D.M.; Danckaert, A.; Munier, S.; Becker, A.; Roux, P.; Zambo, A.; Shorte, S.; Jacob, Y.; Vidalain, P.O.; et al. Microtubule-associated proteins 1 (MAP1) promote human immunodeficiency virus type I (HIV-1) intracytoplasmic routing to the nucleus. J. Biol. Chem. 2015, 290, 4631–4646. [Google Scholar] [CrossRef] [Green Version]
- Konig, R.; Zhou, Y.; Elleder, D.; Diamond, T.L.; Bonamy, G.M.; Irelan, J.T.; Chiang, C.Y.; Tu, B.P.; De Jesus, P.D.; Lilley, C.E.; et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135, 49–60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ferrucci, A.; Nonnemacher, M.R.; Wigdahl, B. Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival. J. Neurovirol. 2013, 19, 239–253. [Google Scholar] [CrossRef] [Green Version]
- Jager, S.; Cimermancic, P.; Gulbahce, N.; Johnson, J.R.; McGovern, K.E.; Clarke, S.C.; Shales, M.; Mercenne, G.; Pache, L.; Li, K.; et al. Global landscape of HIV-human protein complexes. Nature 2011, 481, 365–370. [Google Scholar] [CrossRef]
- Matheson, N.J.; Sumner, J.; Wals, K.; Rapiteanu, R.; Weekes, M.P.; Vigan, R.; Weinelt, J.; Schindler, M.; Antrobus, R.; Costa, A.S.; et al. Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef. Cell Host Microbe 2015, 18, 409–423. [Google Scholar] [CrossRef] [Green Version]
- van Doremalen, N.; Bushmaker, T.; Morris, D.H.; Holbrook, M.G.; Gamble, A.; Williamson, B.N.; Tamin, A.; Harcourt, J.L.; Thornburg, N.J.; Gerber, S.I.; et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N. Engl. J. Med. 2020, 382, 1564–1567. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Monette, A.; Mouland, A.J. Zinc and Copper Ions Differentially Regulate Prion-Like Phase Separation Dynamics of Pan-Virus Nucleocapsid Biomolecular Condensates. Viruses 2020, 12, 1179. https://doi.org/10.3390/v12101179
Monette A, Mouland AJ. Zinc and Copper Ions Differentially Regulate Prion-Like Phase Separation Dynamics of Pan-Virus Nucleocapsid Biomolecular Condensates. Viruses. 2020; 12(10):1179. https://doi.org/10.3390/v12101179
Chicago/Turabian StyleMonette, Anne, and Andrew J. Mouland. 2020. "Zinc and Copper Ions Differentially Regulate Prion-Like Phase Separation Dynamics of Pan-Virus Nucleocapsid Biomolecular Condensates" Viruses 12, no. 10: 1179. https://doi.org/10.3390/v12101179